Structural basis of human LRRK2 membrane recruitment and activation
Abstract
Mutations in LRRK2 are the most common genetic cause of late-onset Parkinsons disease (PD). LRRK2 encodes the leucine-rich repeat kinase 2 (LRRK2), whose kinase activity is regulated by Rab29, a membrane-anchored GTPase. However, molecular mechanisms underlying Rab29-dependent recruitment and activation of LRRK2 remain unclear. Here we report cryo-EM structures of LRRK2-Rab29 complexes in three oligomeric states, illustrating snapshots of key steps during LRRK2 membrane recruitment and activation. Rab29 binds to the ARM domain of LRRK2, and disruption at the interface abrogates LRRK2 kinase activity. Activation of LRRK2 is underpinned by the formation of an unexpected Rab29-induced super-assembly containing two central kinase-active and two peripheral kinase-inactive LRRK2 protomers. Central protomers undergo pronounced oligomerization-associated rearrangements and adopt an active conformation. Our work reveals the structural mechanism for LRRK2s spatial regulation controlled by Rab GTPases, provides mechanistic insights into pathogenic mutations and identifies new opportunities to design LRRK2 inhibitors for PD treatment.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Feed-forward Pathway Drives LRRK2 kinase Membrane Recruitment and Activation
E. G. Vides, A. Adhikari, … S. R. Pfeffer·bioRxiv·Apr 25, 2022
- The structural basis for LRRK2's activation and autoinhibition
Amalia C. Villagran Suarez, Kathryn S. Hatch, … Andrés E. Leschziner·CellPeer-reviewed·Aug 10, 2026
- The phosphorylation status of LRRK2 at the S910/S935 cluster determines its sensitivity to activation by RAB29
Antonio Jesús Lara Ordóñez, Chloé Annicotte, … Jean‐Marc Taymans·bioRxiv·May 26, 2026
- Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activity
Alexia F. Kalogeropulou, Jordana B. Freemantle, … Dario R. Alessi·bioRxiv·Jun 8, 2020
- Elucidating the molecular interplay between LRRK2 and Rab GTPases
Hanwen Zhu, Liam Eade, … Ji Sun·bioRxiv·May 5, 2026
- Membrane remodeling properties of the Parkinson's disease protein LRRK2
X. Wang, J. Espadas, … P. De Camilli·bioRxiv·Aug 10, 2022